Avanos Medical (AVNS) Set to Announce Quarterly Earnings on Tuesday

Share on StockTwits

Avanos Medical (NYSE:AVNS) is scheduled to be announcing its earnings results before the market opens on Tuesday, August 4th. Analysts expect the company to announce earnings of ($0.08) per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

Avanos Medical (NYSE:AVNS) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.16 EPS for the quarter, hitting analysts’ consensus estimates of $0.16. Avanos Medical had a negative net margin of 3.07% and a positive return on equity of 4.09%. The firm had revenue of $180.40 million during the quarter, compared to analyst estimates of $175.15 million. During the same period in the previous year, the business posted $0.15 earnings per share. The business’s revenue for the quarter was up 9.9% on a year-over-year basis. On average, analysts expect Avanos Medical to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Shares of AVNS stock opened at $30.67 on Friday. The company has a 50 day moving average price of $30.11 and a 200-day moving average price of $29.40. Avanos Medical has a 52 week low of $19.46 and a 52 week high of $48.07. The firm has a market capitalization of $1.46 billion, a PE ratio of 28.40, a P/E/G ratio of 4.59 and a beta of 1.19. The company has a quick ratio of 1.96, a current ratio of 2.77 and a debt-to-equity ratio of 0.24.

In other news, Director Gary Blackford purchased 10,000 shares of the stock in a transaction on Friday, May 8th. The shares were acquired at an average price of $28.24 per share, with a total value of $282,400.00. Following the completion of the acquisition, the director now directly owns 29,845 shares of the company’s stock, valued at $842,822.80. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.51% of the stock is owned by insiders.

Several analysts recently issued reports on the stock. KeyCorp cut their target price on shares of Avanos Medical from $48.00 to $45.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Barclays upgraded shares of Avanos Medical from an “underweight” rating to an “equal weight” rating and set a $30.00 target price for the company in a research report on Monday, April 13th. Finally, Morgan Stanley boosted their target price on shares of Avanos Medical from $29.00 to $31.00 and gave the company an “underweight” rating in a research report on Thursday, May 7th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $37.43.

Avanos Medical Company Profile

Avanos Medical, Inc operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life worldwide. It provides a portfolio of products focuses on respiratory and digestive health; pain management solutions; and minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes.

Recommended Story: Which market index is the best?

Earnings History for Avanos Medical (NYSE:AVNS)

Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

State Street Corp Buys 105,181 Shares of Helix Energy Solutions Group Inc
State Street Corp Buys 105,181 Shares of Helix Energy Solutions Group Inc
State Street Corp Has $7.77 Million Stock Position in ADT Inc
State Street Corp Has $7.77 Million Stock Position in ADT Inc
Enel Chile SA –  Stake Lifted by State Street Corp
Enel Chile SA – Stake Lifted by State Street Corp
State Street Corp Sells 47,856 Shares of A10 Networks Inc
State Street Corp Sells 47,856 Shares of A10 Networks Inc
State Street Corp Buys 7,224 Shares of Gerdau SA
State Street Corp Buys 7,224 Shares of Gerdau SA
State Street Corp Grows Position in TPG RE Finance Trust Inc
State Street Corp Grows Position in TPG RE Finance Trust Inc


© 2006-2020 Ticker Report